Literature DB >> 21030717

Intrapericardial, but not extrapericardial, fat is an independent predictor of impaired hyperemic coronary perfusion in coronary artery disease.

Marco Bucci1, Esa Joutsiniemi, Antti Saraste, Sami Kajander, Heikki Ukkonen, Markku Saraste, Mikko Pietilä, Hannu T Sipilä, Mika Teräs, Maija Mäki, K E Juhani Airaksinen, Jaakko Hartiala, Juhani Knuuti, Patricia Iozzo.   

Abstract

OBJECTIVE: To measure intrapericardial fat (IPF), extrapericardial fat (EPF), and myocardial perfusion (MBF) in patients with and without coronary artery disease (CAD), hypothesizing that perfusion is more strongly associated with IPF because it is in direct anatomic contiguity with the myocardium or coronary arteries. METHODS AND
RESULTS: Fat surrounding the heart may increase the risk of CAD and calcification, but little is known about the role of MBF in this relationship. The study included 107 patients with an intermediate likelihood of CAD. Positron emission tomography/computed tomography was used to measure IPF and EPF volumes and coronary artery calcium level, together with MBF at rest and during adenosine-induced hyperemia. Subsequently, all subjects underwent coronary angiography and were grouped for presence/absence of CAD and severity of myocardial hypoperfusion. IPF and EPF levels were higher in men and in patients with CAD (n=85) than in those without CAD (n=22) (P<0.001). EPF was increased regardless of the degree of stenoses (n=45), whereas IPF was selectively increased in subjects with obstructive stenoses (n=40). IPF and EPF levels were both associated with coronary artery calcium scores (R=0.25 and R=0.26, respectively; P<0.02), coronary flow reserve (R=-0.37 and R=-0.38, respectively; P<0.001), and hyperemic MBF (R=-0.36 and R=-0.44, respectively; P<0.0005). Male sex was a strong negative predictor of MBF. After discounting for confounders, myocardial hyperemic perfusion was predicted independently by sex, coronary artery calcium score, and IPF, but not EPF.
CONCLUSIONS: CAD is accompanied by augmented fat depots surrounding the heart, which are negatively related to coronary flow hyperemia. Among fat depots, IPF was the only independent predictor of hyperemic MBF, supporting the hypothesis of a direct paracrine/vasocrine effect.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21030717     DOI: 10.1161/ATVBAHA.110.213827

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  13 in total

1.  Lack of association between epicardial fat volume and extent of coronary artery calcification, severity of coronary artery disease, or presence of myocardial perfusion abnormalities in a diverse, symptomatic patient population: results from the CORE320 multicenter study.

Authors:  Yutaka Tanami; Masahiro Jinzaki; Satoru Kishi; Matthew Matheson; Andrea L Vavere; Carlos E Rochitte; Marc Dewey; Marcus Y Chen; Melvin E Clouse; Christopher Cox; Sachio Kuribayashi; Joao A C Lima; Armin Arbab-Zadeh
Journal:  Circ Cardiovasc Imaging       Date:  2015-03       Impact factor: 7.792

Review 2.  Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features.

Authors:  Gianluca Iacobellis; Antonio C Bianco
Journal:  Trends Endocrinol Metab       Date:  2011-08-16       Impact factor: 12.015

3.  Epicardial adipose tissue thickness as a predictor of impaired microvascular function in patients with non-obstructive coronary artery disease.

Authors:  Mohammed S Alam; Rachel Green; Robert de Kemp; Rob S Beanlands; Benjamin J W Chow
Journal:  J Nucl Cardiol       Date:  2013-06-08       Impact factor: 5.952

Review 4.  The role of perivascular adipose tissue in vascular smooth muscle cell growth.

Authors:  Chao-Yu Miao; Zhi-Yong Li
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

5.  Epicardial fat attenuation, not volume, predicts obstructive coronary artery disease and high risk plaque features in patients with atypical chest pain.

Authors:  Niraj Nirmal Pandey; Sanjiv Sharma; Priya Jagia; Sanjeev Kumar
Journal:  Br J Radiol       Date:  2020-08-26       Impact factor: 3.039

6.  Thoracic fat volume is independently associated with coronary vasomotion.

Authors:  Vincent Dunet; François Feihl; Amin Dabiri; Gilles Allenbach; Bernard Waeber; Raphaël Heinzer; John O Prior
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-08-19       Impact factor: 9.236

7.  Pericardial fat and myocardial perfusion in asymptomatic adults from the Multi-Ethnic Study of Atherosclerosis.

Authors:  Tina E Brinkley; Michael Jerosch-Herold; Aaron R Folsom; J Jeffrey Carr; W Gregory Hundley; Matthew A Allison; David A Bluemke; Gregory L Burke; Moyses Szklo; Jingzhong Ding
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

8.  Arterial and fat tissue inflammation are highly correlated: a prospective 18F-FDG PET/CT study.

Authors:  Jan Bucerius; Venkatesh Mani; Stephanie Wong; Colin Moncrieff; David Izquierdo-Garcia; Josef Machac; Valentin Fuster; Michael E Farkouh; James H F Rudd; Zahi A Fayad
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-01-18       Impact factor: 9.236

9.  The impact of obesity on the relationship between epicardial adipose tissue, left ventricular mass and coronary microvascular function.

Authors:  M J Bakkum; I Danad; M A J Romijn; W J A Stuijfzand; R M Leonora; I I Tulevski; G A Somsen; A A Lammertsma; C van Kuijk; A C van Rossum; P G Raijmakers; P Knaapen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-06-09       Impact factor: 9.236

10.  Ambient fine particulate matter and ozone exposures induce inflammation in epicardial and perirenal adipose tissues in rats fed a high fructose diet.

Authors:  Lixian Sun; Cuiqing Liu; Xiaohua Xu; Zhekang Ying; Andrei Maiseyeu; Aixia Wang; Katryn Allen; Ryan P Lewandowski; Lori A Bramble; Masako Morishita; James G Wagner; J Dvonch; Zhichao Sun; Xiaowei Yan; Robert D Brook; Sanjay Rajagopalan; Jack R Harkema; Qinghua Sun; Zhongjie Fan
Journal:  Part Fibre Toxicol       Date:  2013-08-22       Impact factor: 9.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.